• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

Furaltadone-D5 (CAS No. 1015855-64-7): An Overview of a Promising Isotope-Labeled Compound in Pharmaceutical Research

Furaltadone-D5 (CAS No. 1015855-64-7) is a deuterium-labeled derivative of the nitrofuran antibiotic furaltadone. This compound has gained significant attention in recent years due to its potential applications in pharmaceutical research, particularly in the areas of drug metabolism, pharmacokinetics, and bioanalytical methods. The introduction of deuterium atoms into the molecular structure of furaltadone offers several advantages, including enhanced stability and improved detection sensitivity in mass spectrometry-based analyses.

The chemical structure of Furaltadone-D5 is characterized by the presence of five deuterium atoms, which are strategically positioned to maximize the compound's stability and analytical performance. The deuterium atoms replace hydrogen atoms at specific sites, leading to a more robust molecule that is less susceptible to metabolic degradation. This property is particularly valuable in the development of bioanalytical methods for the quantification of furaltadone and its metabolites in biological matrices.

In the context of drug metabolism studies, Furaltadone-D5 serves as an internal standard for the accurate quantification of furaltadone and its metabolites. The use of an isotope-labeled internal standard helps to correct for variations in sample preparation and instrumental response, thereby improving the precision and accuracy of the analytical results. Recent studies have demonstrated the effectiveness of Furaltadone-D5 in this role, with high recovery rates and low matrix effects observed in various biological matrices such as plasma, urine, and tissue homogenates.

The pharmacokinetic properties of Furaltadone-D5 have also been extensively studied. Research has shown that the deuterium-labeled compound exhibits similar absorption, distribution, metabolism, and excretion (ADME) profiles compared to its non-labeled counterpart. This similarity is crucial for ensuring that the pharmacokinetic parameters derived from studies using Furaltadone-D5 are representative of those observed with the native compound. Additionally, the enhanced stability of Furaltadone-D5 allows for more reliable long-term storage and transport, which is particularly important for multi-center clinical trials.

Bioanalytical methods developed for the quantification of Furaltadone-D5 have leveraged advanced mass spectrometry techniques such as liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods offer high sensitivity and specificity, enabling the detection and quantification of trace levels of furaltadone and its metabolites in complex biological samples. The use of stable isotope dilution techniques further enhances the accuracy and reliability of these analyses.

The application of Furaltadone-D5 in pharmaceutical research extends beyond drug metabolism and pharmacokinetics. It has also been used in mechanistic studies to investigate the biological effects and toxicity profiles of nitrofuran antibiotics. By providing a stable and reliable reference standard, Furaltadone-D5 facilitates a deeper understanding of the molecular mechanisms underlying the therapeutic and adverse effects of these compounds.

In conclusion, Furaltadone-D5 (CAS No. 1015855-64-7) represents a valuable tool in pharmaceutical research. Its unique properties as a deuterium-labeled compound make it an essential component in bioanalytical methods, drug metabolism studies, and mechanistic investigations. As research continues to advance in these areas, the importance of compounds like Furaltadone-D5 is likely to grow, contributing to the development of safer and more effective therapeutic agents.

• 139-91-3(Furaltadone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)